| Q44167625 | A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis. |
| Q35134442 | Association between the Hemoglobin Level and Cardiothoracic Ratio in Patients on Incident Dialysis. |
| Q37695746 | Choosing Wisely: The Canadian Society of Nephrology's List of 5 Items Physicians and Patients Should Question |
| Q37280782 | Clinical factors and the decision to transfuse chronic dialysis patients |
| Q89640182 | Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis |
| Q60960606 | Established and Emerging Concepts to Treat Imbalances of Iron Homeostasis in Inflammatory Diseases |
| Q37621547 | Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. |
| Q54203232 | Hepcidin protects against lethal E. coli sepsis in mice inoculated with isolates from septic patients. |
| Q90288544 | Impact of Recent Clinical Trials on Nephrology Practice: Are We in a Stagnant Era? |
| Q91962931 | Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease |
| Q44105593 | Increased rate of force development and neuromuscular activity after high-load resistance training in patients undergoing dialysis |
| Q92446436 | Intravenous iron therapy in heart failure: a different perspective |
| Q48011055 | Iron deficiency beyond erythropoiesis: should we be concerned? |
| Q37341829 | Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation |
| Q92562108 | Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study |
| Q42355403 | Iron replacement therapy: entering the new era without misconceptions, but more research is needed |
| Q55089372 | Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. |
| Q33625700 | Long-term effects of oral L-carnitine supplementation on anemia in chronic hemodialysis |
| Q35659768 | Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review |
| Q38213502 | Next-generation phosphate binders: focus on iron-based binders |
| Q55416565 | Obesity may be erythropoietin dose-saving in hemodialysis patients. |
| Q44995033 | Perihospitalization patterns of hemoglobin levels and erythropoiesis-stimulating agent doses in US hemodialysis patients, 1998-2009. |
| Q89731552 | Predictive value of electrocardiography-gated myocardial perfusion imaging to new-onset heart failure in patients with chronic kidney disease: findings from the J-ACCESS 3 study |
| Q48225857 | Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease |
| Q36771312 | Regulation of platelet count by erythropoiesis-stimulating agents - iron axis in hemodialysis patients |
| Q90009539 | Relationship between anti-erythropoietin receptor autoantibodies and responsiveness to erythropoiesis-stimulating agents in patients on hemodialysis: a multi-center cross-sectional study |
| Q42343473 | Renal association clinical practice guideline in post-operative care in the kidney transplant recipient |
| Q92134307 | Risk Factors Before Dialysis Predominate as Mortality Predictors in Diabetic Maintenance Dialysis patients |
| Q47114967 | Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease |
| Q41968095 | Save life and improve quality: report from the 5th Congress of International Society for Hemodialysis |
| Q46324575 | Serum Iron Protects from Renal Postischemic Injury. |
| Q28646953 | Severity of Anemia Predicts Hospital Length of Stay but Not Readmission in Patients with Chronic Kidney Disease: A Retrospective Cohort Study |
| Q89719090 | The Biomarker TCONS_00016233 Drives Septic AKI by Targeting the miR-22-3p/AIFM1 Signaling Axis |
| Q35801832 | The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients |
| Q91686272 | Treatment options for anemia in the elderly |
| Q34325372 | Urinary sodium excretion has positive correlation with activation of urinary renin angiotensin system and reactive oxygen species in hypertensive chronic kidney disease. |
| Q46213470 | Uses and interpretation of iron studies in patients on chronic dialysis |